Clinical Trial Update: Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing crenolanib to midostaurin after induction and consolidation chemotherapy in newly diagnosed FLT3-mutated acute myeloid leukemia has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Crenolanib (Crenolanib)
• Midostaurin (midostaurin)

Snippet

Sponsor: Arog Pharmaceuticals, Inc. | Conditions: Newly Diagnosed FLT3 Mutated AML | Phase 3 | Status: COMPLETED